Inactive Instrument
Celladon Corp Stock Nasdaq
Stocks
US15117E1073
Biotechnology & Medical Research
OTC Markets Traded| Market Cap | 12.59M 10.78M 10.08M 9.23M 17.32M 1.2B 17.56M 119M 46.42M 605M 47.26M 46.22M 2B | P/E 2022 |
-0.51x | P/E 2023 | -0.13x |
|---|---|---|---|---|---|
| Enterprise Value | 27.95M 23.93M 22.38M 20.49M 38.46M 2.67B 38.98M 265M 103M 1.34B 105M 103M 4.44B | EV / Sales 2022 |
-836,796x | EV / Sales 2023 | 1,605,487x |
| Free-Float |
86.47% | Yield 2022 * |
-
| Yield 2023 | - |
| 1 day | -4.91% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Tech/Sci/R&D Officer | 59 | 18/04/2022 | |
Douglas Staut
PRN | Corporate Officer/Principal | - | 19/04/2024 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.91% | -10.06% | - | - | 12.59M | |
| +1.09% | +3.39% | +3.50% | +25.49% | 51.22B | |
| -1.07% | +3.69% | +479.26% | +607.16% | 45.38B | |
| +1.44% | +5.19% | +21.06% | +93.98% | 41.97B | |
| +1.47% | +7.58% | +35.29% | +21.42% | 42.15B | |
| -0.93% | -4.80% | +17.39% | +46.60% | 31.95B | |
| -0.60% | +2.87% | - | - | 16.73B | |
| +1.32% | +6.67% | +33.29% | +148.62% | 17.1B | |
| +0.03% | +3.91% | +5.84% | +35.04% | 14.76B | |
| +1.28% | +4.95% | +84.98% | +48.41% | 13.91B | |
| Average | -0.09% | +3.19% | +85.08% | +128.34% | 30.58B | |
| Weighted average by Cap. | +0.47% | +3.13% | +103.29% | +150.63% |
| 2022 | 2023 | |
|---|---|---|
| Net sales | 13.48 11.55 10.8 9.89 18.56 1.29K 18.81 127.7 49.73 647.7 50.63 49.52 2.14K | 15.77 13.51 12.63 11.56 21.71 1.51K 22 149.38 58.18 757.65 59.22 57.92 2.51K |
| Net income | -96.78M -82.87M -77.5M -70.95M -133M -9.26B -135M -917M -357M -4.65B -363M -355M -15.37B | -74.96M -64.19M -60.03M -54.96M -103M -7.17B -105M -710M -276M -3.6B -281M -275M -11.91B |
| Net Debt | -63.29M -54.2M -50.69M -46.4M -87.11M -6.06B -88.28M -599M -233M -3.04B -238M -232M -10.05B | 15.36M 13.15M 12.3M 11.26M 21.14M 1.47B 21.42M 145M 56.65M 738M 57.67M 56.4M 2.44B |
Employees
-
